Últimas subidas - Macular Diseases - Acquired
|
Elmiron (pentasosan polysulfate) Macular Toxicityvista 113 veces77 year old female who had been on Elmiron for 20 years and stopped it 2 years agoMarzo 15, 2026
|
|
Elmiron (pentasosan polysulfate) Macular Toxicityvista 93 veces77 year old female who had been on Elmiron for 20 years and stopped it 2 years agoMarzo 15, 2026
|
|
Elmiron (pentasosan polysulfate) Macular Toxicityvista 94 veces77 year old female who had been on Elmiron for 20 years and stopped it 2 years agoMarzo 15, 2026
|
|
Elmiron (pentasosan polysulfate) Macular Toxicityvista 42 veces77 year old female who had been on Elmiron for 20 years and stopped it 2 years agoMarzo 15, 2026
|
|
Elmiron (pentasosan polysulfate) Macular Toxicityvista 44 veces77 year old female who had been on Elmiron for 20 years and stopped it 2 years agoMarzo 15, 2026
|
|
Elmiron (pentasosan polysulfate) Macular Toxicityvista 49 veces77 year old female who had been on Elmiron for 20 years and stopped it 2 years agoMarzo 15, 2026
|
|
Elmiron (pentasosan polysulfate) Macular Toxicityvista 52 veces77 year old female who had been on Elmiron for 20 years and stopped it 2 years agoMarzo 15, 2026
|
|
Elmiron (pentasosan polysulfate) Macular Toxicityvista 52 veces77 year old female who had been on Elmiron for 20 years and stopped it 2 years agoMarzo 15, 2026
|
|
Elmiron (pentasosan polysulfate) Macular Toxicityvista 44 veces77 year old female who had been on Elmiron for 20 years and stopped it 2 years agoMarzo 15, 2026
|
|
Elmiron (pentasosan polysulfate) Macular Toxicityvista 46 veces77 year old female who had been on Elmiron for 20 years and stopped it 2 years agoMarzo 15, 2026
|
|
Elmiron (pentasosan polysulfate) Macular Toxicityvista 46 veces77 year old female who had been on Elmiron for 20 years and stopped it 2 years agoMarzo 15, 2026
|
|
Elmiron (pentasosan polysulfate) Macular Toxicityvista 47 veces77 year old female who had been on Elmiron for 20 years and stopped it 2 years agoMarzo 15, 2026
|
|
Elmiron (pentasosan polysulfate) Macular Toxicityvista 50 veces77 year old female who had been on Elmiron for 20 years and stopped it 2 years agoMarzo 15, 2026
|
|
Elmiron (pentasosan polysulfate) Macular Toxicityvista 48 veces77 year old female who had been on Elmiron for 20 years and stopped it 2 years agoMarzo 15, 2026
|
|
MacTel with foveal atrophy in both eyesvista 40 veces62 year old female with 20/50 OD, 20/40 OS.Febrero 18, 2026
|
|
MacTel with foveal atrophy in both eyesvista 40 veces62 year old female with 20/50 OD, 20/40 OS.Febrero 18, 2026
|
|
MacTel with foveal atrophy in both eyesvista 35 veces62 year old female with 20/50 OD, 20/40 OS.Febrero 18, 2026
|
|
MacTel with foveal atrophy in both eyesvista 41 veces62 year old female with 20/50 OD, 20/40 OS.Febrero 18, 2026
|
|
MacTel with foveal atrophy in both eyesvista 40 veces62 year old female with 20/50 OD, 20/40 OS.Febrero 18, 2026
|
|
MacTel with foveal atrophy in both eyesvista 40 veces62 year old female with 20/50 OD, 20/40 OS.Febrero 18, 2026
|
|
MacTel with foveal atrophy in both eyesvista 41 veces62 year old female with 20/50 OD, 20/40 OS.Febrero 18, 2026
|
|
MacTel with foveal atrophy in both eyesvista 42 veces62 year old female with 20/50 OD, 20/40 OS.Febrero 18, 2026
|
|
MacTel with foveal atrophy in both eyesvista 42 veces62 year old female with 20/50 OD, 20/40 OS.Febrero 18, 2026
|
|
MacTel with foveal atrophy in both eyesvista 42 veces62 year old female with 20/50 OD, 20/40 OS.Febrero 18, 2026
|
|
MacTel with foveal atrophy in both eyesvista 44 veces62 year old female with 20/50 OD, 20/40 OS.Febrero 18, 2026
|
|
MacTel with foveal atrophy in both eyesvista 40 veces62 year old female with 20/50 OD, 20/40 OS.Febrero 18, 2026
|
|
MacTel with foveal atrophy in both eyesvista 48 veces62 year old female with 20/50 OD, 20/40 OS.Febrero 18, 2026
|
|
MacTel with foveal atrophy in both eyesvista 36 veces62 year old female with 20/50 OD, 20/40 OS.Febrero 18, 2026
|
|
MacTel with foveal atrophy in both eyesvista 48 veces62 year old female with 20/50 OD, 20/40 OS.Febrero 18, 2026
|
|
Latanoprost induced CMEvista 51 veces89 year old man with CME from latanoprost that cleared within one month of stopping the medicationNoviembre 23, 2025
|
|
Latanoprost induced CMEvista 68 veces89 year old man with CME from latanoprost that cleared within one month of stopping the medicationNoviembre 23, 2025
|
|
Latanoprost induced CMEvista 60 veces89 year old man with CME from latanoprost that cleared within one month of stopping the medicationNoviembre 23, 2025
|
|
Latanoprost induced CMEvista 54 veces89 year old man with CME from latanoprost that cleared within one month of stopping the medicationNoviembre 23, 2025
|
|
Latanoprost induced CMEvista 62 veces89 year old man with CME from latanoprost that cleared within one month of stopping the medicationNoviembre 23, 2025
|
|
Latanoprost induced CMEvista 61 veces89 year old man with CME from latanoprost that cleared within one month of stopping the medicationNoviembre 23, 2025
|
|
Latanoprost induced CMEvista 57 veces89 year old man with CME from latanoprost that cleared within one month of stopping the medicationNoviembre 23, 2025
|
|
Latanoprost induced CMEvista 77 veces89 year old man with CME from latanoprost that cleared within one month of stopping the medicationNoviembre 23, 2025
|
|
Latanoprost induced CMEvista 46 veces89 year old man with CME from latanoprost that cleared within one month of stopping the medicationNoviembre 23, 2025
|
|
Latanoprost induced CMEvista 52 veces89 year old man with CME from latanoprost that cleared within one month of stopping the medicationNoviembre 23, 2025
|
|
Latanoprost induced CMEvista 60 veces89 year old man with CME from latanoprost that cleared within one month of stopping the medicationNoviembre 23, 2025
|
|
Latanoprost induced CMEvista 65 veces89 year old man with CME from latanoprost that cleared within one month of stopping the medicationNoviembre 23, 2025
|
|
Latanoprost induced CMEvista 66 veces89 year old man with CME from latanoprost that cleared within one month of stopping the medicationNoviembre 23, 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvista 79 veces74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15Agosto 17, 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvista 74 veces74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15Agosto 17, 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvista 72 veces74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15Agosto 17, 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvista 67 veces74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15Agosto 17, 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvista 64 veces74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15Agosto 17, 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvista 70 veces74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15Agosto 17, 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvista 69 veces74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15Agosto 17, 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvista 57 veces74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15Agosto 17, 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvista 62 veces74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15Agosto 17, 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvista 60 veces74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15Agosto 17, 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvista 70 veces74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15Agosto 17, 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvista 60 veces74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15Agosto 17, 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvista 85 veces74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15Agosto 17, 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvista 61 veces74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15Agosto 17, 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvista 69 veces74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15Agosto 17, 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvista 52 veces74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15Agosto 17, 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvista 73 veces74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15Agosto 17, 2025
|
|
Hydroxychloroquine Toxicityvista 96 veces60 year old female received 6.5 mg/kg Plaquenil for 15 years and developed toxicity. VA 20/40 OD, 20/20 OSDiciembre 22, 2024
|
|
Hydroxychloroquine Toxicityvista 120 veces60 year old female received 6.5 mg/kg Plaquenil for 15 years and developed toxicity. VA 20/40 OD, 20/20 OSDiciembre 22, 2024
|
|
Hydroxychloroquine Toxicityvista 120 veces60 year old female received 6.5 mg/kg Plaquenil for 15 years and developed toxicity. VA 20/40 OD, 20/20 OSDiciembre 22, 2024
|
|
Hydroxychloroquine Toxicityvista 117 veces60 year old female received 6.5 mg/kg Plaquenil for 15 years and developed toxicity. VA 20/40 OD, 20/20 OSDiciembre 22, 2024
|
|
Hydroxychloroquine Toxicityvista 108 veces60 year old female received 6.5 mg/kg Plaquenil for 15 years and developed toxicity. VA 20/40 OD, 20/20 OSDiciembre 22, 2024
|
|
Hydroxychloroquine Toxicityvista 101 veces60 year old female received 6.5 mg/kg Plaquenil for 15 years and developed toxicity. VA 20/40 OD, 20/20 OSDiciembre 22, 2024
|
|
Hydroxychloroquine Toxicityvista 96 veces60 year old female received 6.5 mg/kg Plaquenil for 15 years and developed toxicity. VA 20/40 OD, 20/20 OSDiciembre 22, 2024
|
|
Hydroxychloroquine Toxicityvista 127 veces60 year old female received 6.5 mg/kg Plaquenil for 15 years and developed toxicity. VA 20/40 OD, 20/20 OSDiciembre 22, 2024
|
|
Hydroxychloroquine Toxicityvista 138 veces60 year old female received 6.5 mg/kg Plaquenil for 15 years and developed toxicity. VA 20/40 OD, 20/20 OSDiciembre 22, 2024
|
|
Hydroxychloroquine Toxicityvista 104 veces60 year old female received 6.5 mg/kg Plaquenil for 15 years and developed toxicity. VA 20/40 OD, 20/20 OSDiciembre 22, 2024
|
|
Pseudophakic CME chronicvista 87 veces74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/TimololNoviembre 06, 2024
|
|
Pseudophakic CME chronicvista 93 veces74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/TimololNoviembre 06, 2024
|
|
Pseudophakic CME chronicvista 109 veces74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/TimololNoviembre 06, 2024
|
|
Pseudophakic CME chronicvista 108 veces74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/TimololNoviembre 06, 2024
|
|
Pseudophakic CME chronicvista 106 veces74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/TimololNoviembre 06, 2024
|
|
Pseudophakic CME chronicvista 103 veces74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/TimololNoviembre 06, 2024
|
|
Pseudophakic CME chronicvista 106 veces74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/TimololNoviembre 06, 2024
|
|
Pseudophakic CME chronicvista 109 veces74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/TimololNoviembre 06, 2024
|
|
Pseudophakic CME chronicvista 96 veces74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/TimololNoviembre 06, 2024
|
|
Pseudophakic CME chronicvista 96 veces74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/TimololNoviembre 06, 2024
|
|
Pseudophakic CME chronicvista 112 veces74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/TimololNoviembre 06, 2024
|
|
Pseudophakic CME chronicvista 98 veces74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/TimololNoviembre 06, 2024
|
|
Pseudophakic CME chronicvista 94 veces74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/TimololNoviembre 06, 2024
|
|
Pseudophakic CME chronicvista 93 veces74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/TimololNoviembre 06, 2024
|
|
Pseudophakic CME chronicvista 114 veces74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/TimololNoviembre 06, 2024
|
|
Pseudophakic CME chronicvista 93 veces74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/TimololNoviembre 06, 2024
|
|
Pseudophakic CME chronicvista 95 veces74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/TimololNoviembre 06, 2024
|
|
Pseudophakic CME chronicvista 99 veces74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/TimololNoviembre 06, 2024
|
|
Pseudophakic CME chronicvista 117 veces74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/TimololNoviembre 06, 2024
|
|
Pseudophakic CME chronicvista 129 veces74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/TimololNoviembre 06, 2024
|
|
Pseudophakic CME chronicvista 105 veces74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/TimololNoviembre 06, 2024
|
|
Pseudophakic CME chronicvista 100 veces74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/TimololNoviembre 06, 2024
|
|
Macular Telangetasia MacTel - Nonproliferativevista 110 veces60 year old non-diabetic female with gradual vision loss for 20 years. VA 20/80 OD, 20/63 OSSeptiembre 17, 2024
|
|
Macular Telangetasia MacTel - Nonproliferativevista 109 veces60 year old non-diabetic female with gradual vision loss for 20 years. VA 20/80 OD, 20/63 OSSeptiembre 17, 2024
|
|
Macular Telangetasia MacTel - Nonproliferativevista 115 veces60 year old non-diabetic female with gradual vision loss for 20 years. VA 20/80 OD, 20/63 OSSeptiembre 17, 2024
|
|
Macular Telangetasia MacTel - Nonproliferativevista 109 veces60 year old non-diabetic female with gradual vision loss for 20 years. VA 20/80 OD, 20/63 OSSeptiembre 17, 2024
|
|
Macular Telangetasia MacTel - Nonproliferativevista 93 veces60 year old non-diabetic female with gradual vision loss for 20 years. VA 20/80 OD, 20/63 OSSeptiembre 17, 2024
|
|
Macular Telangetasia MacTel - Nonproliferativevista 93 veces60 year old non-diabetic female with gradual vision loss for 20 years. VA 20/80 OD, 20/63 OSSeptiembre 17, 2024
|
|
Macular Telangetasia MacTel - Nonproliferativevista 87 veces60 year old non-diabetic female with gradual vision loss for 20 years. VA 20/80 OD, 20/63 OSSeptiembre 17, 2024
|
|
Macular Telangetasia MacTel - Nonproliferativevista 107 veces60 year old non-diabetic female with gradual vision loss for 20 years. VA 20/80 OD, 20/63 OSSeptiembre 17, 2024
|
|
Macular Telangetasia MacTel - Nonproliferativevista 92 veces60 year old non-diabetic female with gradual vision loss for 20 years. VA 20/80 OD, 20/63 OSSeptiembre 17, 2024
|
|
| 2319 archivos en 24 página(s) |
1 |
 |
|
|
|
|
|
|
|
|
|
